Folate

vitamin

Folate, or Vitamin B9, is a water-soluble vitamin naturally present in many foods. It plays a vital role in several critical functions, including DNA synthesis, cell division, and the production of red blood cells. These roles are particularly significant during periods of rapid growth, such as pregnancy and infancy. Beyond cellular health, folate is essential for metabolizing homocysteine. Maintaining healthy homocysteine levels is associated with cardiovascular health. It also works alongside other B vitamins to support neurological function and the production of neurotransmitters, which contribute to mood regulation and cognitive health. Folic acid, the synthetic form of folate, is frequently used in supplements and fortified foods due to its stability. Adequate intake is necessary to prevent deficiency, though high doses of folic acid can potentially mask a Vitamin B12 deficiency. Ensuring sufficient intake helps support developmental health and cellular maintenance.

Natural sources
Leafy green vegetables (e.g., spinach, kale)Legumes (e.g., lentils, beans)EggsLiverAsparagusBroccoliFortified cerealsCitrus fruits

Ingredient forms

No public comparison lists found.

Timing & Intake
AnytimeWith foodTake with Food
Taking folate with food may improve absorption and help minimize potential stomach discomfort.
Daily Intake
RDA (Men)400 mcg
RDA (Women)400 mcg
RDI400 mcg
Optimal Dosage
Minimum400 mcg
Maximum800 mcg
Safety & Toxicity
Upper Limit (UL)1000 mcg
Toxicity Threshold15000 mcg
Toxicity Effectmasking B₁₂ deficiency
4 safety notes
  • High doses of folic acid (the synthetic form of folate) can mask a Vitamin B12 deficiency, which can lead to irreversible neurological damage if left undiagnosed and untreated. Individuals, especially older adults or those following vegan/vegetarian diets, should ensure adequate Vitamin B12 intake or have B12 levels checked if taking high-dose folate supplements.
  • Individuals with a history of cancer should consult a healthcare professional before taking high doses of folate, as some research suggests it might influence cancer cell growth.
  • Consult a healthcare provider before taking if pregnant, breastfeeding, or on medications, especially antiepileptic drugs, methotrexate, or certain antibiotics, as folate can interact with them.
  • Do not exceed recommended dosages without medical supervision.
Goals
Anti-Aging
Impact
Highest effect
Typical dose:400–800 mcg

Proper methylation is essential for turning genes on and off correctly, a process that can become dysregulated during aging. Folate, preferably in its active L-methylfolate form, is a primary methyl donor that supports this process. Maintaining adequate folate levels helps ensure genomic stability and reduces the risk of elevated homocysteine, a significant factor in vascular aging.

Focuses on
Epigenetic agingCognitive healthArterial stiffnessTelomere maintenanceHomocysteine management
Most relevant for
Older adults seeking to support long-term cognitive and vascular health, particularly in populations where dietary intake is low or food is not fortified.

Potential benefits

  • Cellular and Epigenetic Support.Unconfirmed. Higher folate status is associated with laboratory markers of slower biological aging, such as maintained telomere length and reduced epigenetic age deviation. This is unconfirmed because changes in laboratory markers have not yet been proven to extend lifespan or improve health span in humans.
  • Cognitive Longevity.Unconfirmed. Adequate blood folate levels are linked to slower cognitive decline in long-term observational studies of older adults. This is unconfirmed as clinical trials have not consistently demonstrated that supplementation prevents cognitive impairment in those with already sufficient levels.
  • Vascular Health.Unconfirmed. High dietary folate intake is associated with a slower progression of arterial stiffness, a major factor in vascular aging. This is unconfirmed because it is unclear if supplements provide the same protection as naturally occurring dietary folate.

Limitations

  • Confounding Factors.Many anti-aging associations are observational and may be influenced by smoking status, kidney function, or overall diet rather than folate alone.
  • Limited Physical Impact.Research has found no significant link between folate levels and improvements in physical performance, such as grip strength, or changes in brain volume over time.
  • Diminishing Returns.Evidence suggests a saturation point where folate intake above approximately 500 micrograms per day provides no additional benefit for cellular aging markers.
Things to consider

Clinical benefits for sensory functions like hearing have primarily been observed in older adults with high homocysteine living in regions without mandatory folic acid fortification.

Study evidence

16 studies

Adequate folate status is associated with healthier aging markers and, in some studies, less cognitive decline. These associations do not establish that folate supplements slow aging or extend life, and benefits beyond correcting inadequate status remain uncertain.

View goal
Brain Health
Impact
Highest effect
Typical dose:400–800 mcg

Folate (Vitamin B9) is a crucial cofactor in the production of key neurotransmitters like dopamine, serotonin, and norepinephrine. It is also vital for the methylation cycle, which helps keep homocysteine levels in check. Elevated homocysteine is a known risk factor for vascular damage in the brain and cognitive decline, making folate a foundational nutrient for long-term brain health.

Focuses on
Cognitive FunctionMemory SupportHomocysteine RegulationPrenatal Brain DevelopmentInformation Processing Speed
Most relevant for
Individuals with low folate levels or high homocysteine, and pregnant people supporting fetal neurodevelopment.

Potential benefits

  • Cognitive Support in Impairment.Meta-analyses suggest that folic acid supplementation may improve global cognitive function, memory, and attention in adults diagnosed with mild cognitive impairment or Alzheimer's disease.
  • Neurodevelopmental Foundation.Adequate folate levels in early pregnancy are essential for fetal brain development; deficiency is associated with smaller brain volume and poorer cognitive performance in offspring.
  • Homocysteine Reduction.Folate supplementation consistently lowers levels of homocysteine, a biomarker linked to vascular-related cognitive decline and increased risk of dementia.

Limitations

  • Dependent on Baseline Status.Cognitive benefits are rarely seen in healthy, well-nourished adults or in regions where mandatory food fortification has already optimized folate levels.
  • Inconsistent Memory Effects.While some trials show benefit, multiple systematic reviews have found no significant overall effect of folate on memory status in general older populations.
  • Omega-3 Status Interaction.The effectiveness of folate for slowing cognitive aging may be limited to individuals who also have adequate omega-3 fatty acid levels.
Things to consider

Folic acid intake can mask the anemia of vitamin B12 deficiency, potentially allowing neurological damage to progress undiagnosed. Some observational studies have linked very high folate intake with a faster rate of cognitive decline in older adults.

Study evidence

90 studies

Folate is important for brain development, and low status is associated with poorer cognition. Supplementation may help selected people with low folate or cognitive impairment, but benefits are inconsistent and extra folate has not been shown to broadly protect already well-nourished adults from cognitive decline.

View goal
Cognitive Support
Impact
Highest effect
Typical dose:400–800 mcg

Folate's role is as critical as Vitamin B12's for neurological function.

Focuses on
Homocysteine regulationProcessing speedMemory supportAge-related declineFetal brain development
Most relevant for
Older adults with low folate status or elevated homocysteine, particularly in regions without mandatory food fortification.

Potential benefits

  • Homocysteine Regulation.Folate helps lower homocysteine levels, a blood marker associated with brain atrophy and an increased risk of cognitive decline in the elderly.
  • Support for Mild Impairment.Supplemental folate may help preserve global functioning, processing speed, and IQ scores in adults already experiencing mild cognitive impairment or existing folate insufficiency.
  • Early Neurodevelopment.Adequate maternal intake during early pregnancy is positively associated with language and cognitive development in offspring.

Limitations

  • Baseline Status Impact.Supplemental benefits are significantly reduced or absent in populations already receiving adequate folate through mandatory grain fortification or nutrient-rich diets.
  • Inconsistent Memory Effects.Meta-analyses show that while global cognition may improve, specific memory scores often show no significant change in healthy or unselected older adults.
  • Dementia Prevention Uncertainty.Although low folate is a risk factor, clinical trials have not consistently proven that supplementation prevents the development of Alzheimer's disease or dementia.
Things to consider

High folate intake can mask Vitamin B12 deficiency, potentially allowing neurological damage to progress undetected. Chronic intake exceeding 1,000 mcg per day has been associated with poorer cognitive outcomes in some studies.

Study evidence

68 studies

Folate supports normal brain function, and supplementation may help some older adults with low folate status or cognitive impairment. Benefits are inconsistent when folate is already adequate, and the available research does not establish routine supplementation as a way to prevent dementia.

View goal
Detoxification
Impact
Highest effect
Typical dose:400–800 mcg

Folate, along with B6 and B12, is essential for the methylation cycle, a major route for neutralizing hormones and various toxins.

Focuses on
Arsenic methylationLiver enzyme regulationHeavy metal levelsDrug-induced liver injuryPhase II methylation
Most relevant for
Individuals with low folate status, environmental arsenic exposure, or those taking medications like methotrexate that impact folate metabolism.

Potential benefits

  • Arsenic Detoxification Support.Folate facilitates the methylation and subsequent urinary excretion of arsenic, particularly in individuals with low baseline folate levels.
  • Liver Protection During Medication.Supplementation helps maintain normal liver enzyme levels in individuals taking medications like methotrexate that interfere with folate metabolism.
  • Methylation Pathway Role.Unconfirmed. As a critical methyl donor, folate supports Phase II detoxification pathways essential for neutralizing hormones and various toxins.

Limitations

  • Inconsistent Fatty Liver Outcomes.While higher folate is associated with lower fatty liver risk, clinical trials have not consistently shown that supplements improve liver fat or enzymes in existing NAFLD.
  • Status-Dependent Efficacy.The evidence for heavy metal detoxification is strongest for individuals with existing folate deficiency; benefits for those with adequate intake are less established.
  • Limited Heavy Metal Evidence.Reported associations between folate and lower blood levels of lead and cadmium are observational and do not prove folate actively removes these metals.

Study evidence

16 studies

Folate supports arsenic processing, with evidence of benefit in arsenic-exposed people who have low folate status. This does not establish a general detoxification effect: links with other metals and liver health are largely observational, and supplementation has not consistently improved fatty liver outcomes.

View goal
General Health
Impact
Highest effect
Typical dose:400–1000 mcg

Folate, particularly in its active methylfolate form, is a key player in the one-carbon cycle, which regulates genetic expression and cellular function throughout the body. Adequate folate levels are vital for cardiovascular health (by regulating homocysteine), mood balance, and cellular growth.

Focuses on
Healthy fetal developmentMortality risk reductionCardiovascular supportDNA synthesisCellular metabolism
Most relevant for
Individuals seeking to maintain long-term wellness, particularly those with low dietary intake or women of reproductive age.

Potential benefits

  • Healthy Fetal Development.Established evidence shows that adequate intake and supplementation significantly reduce the risk of neural tube defects and support healthy birth outcomes.
  • Long-Term Longevity Support.Large cohort studies associate higher dietary folate intake and normal serum levels with a reduced risk of all-cause and cardiovascular mortality in various populations.
  • Cardiovascular Health.Folate supports the regulation of homocysteine levels; maintaining adequate status is linked to a lower risk of heart-related health issues.

Limitations

  • Inconsistent Mental Health Results.While low folate is associated with mood disorders, clinical trials show mixed results for supplementation in treating depression or schizophrenia.
  • Upper Limit Uncertainty.Some research suggests a J-shaped relationship where very high blood levels or excessive supplementation do not provide additional mortality benefits and may carry risks.
  • Indirect Associations.In some cases, low folate levels may be a biomarker of poor health or diet rather than a direct cause of specific chronic diseases.
Things to consider

Excessive folic acid supplementation may be associated with increased risks in specific populations, such as those with existing colorectal lesions or high cardiovascular risk.

Study evidence

80 studies

Folate has an established role in healthy fetal development, and low folate status is associated with poorer health in several populations. Beyond these specific needs, the available research does not establish that extra folate broadly improves health or longevity in people with adequate status.

View goal
Mental Focus
Impact
Highest effect
Typical dose:400–800 mcg

Folate (as methylfolate) is a critical component of the one-carbon metabolism cycle, which is directly involved in producing the methyl donors required for neurotransmitter synthesis. Deficiencies in folate can impair this process, leading to low mood and poor concentration.

Focuses on
Processing speedCognitive agingNeurotransmitter synthesisDeficiency support
Most relevant for
Older adults with age-related cognitive decline or individuals looking to address a folate deficiency.

Potential benefits

  • Information Processing Speed.Long-term supplementation in older adults with elevated homocysteine has been shown to significantly improve information processing and sensorimotor speed.
  • Cognitive Health Maintenance.In individuals with mild cognitive impairment, daily folate may improve verbal IQ and specific memory span tasks over a 24-month period.
  • Concentration Support (Unproven).Unconfirmed. Folate is essential for the production of neurotransmitters like dopamine, but its ability to improve focus in healthy individuals with normal folate levels is not established.

Limitations

  • Ineffective for ADHD Focus.Clinical evidence shows L-methylfolate does not improve attention or executive function in adults with ADHD and may potentially reduce the efficacy of stimulant medication.
  • B12-Dependent Risks.High folate status in the presence of low Vitamin B12 has been linked to lower cognitive test scores and increased risks of anemia in older adults.
  • No Effect in Healthy Adults.Short-term supplementation does not appear to enhance psychomotor performance or attention in healthy individuals who already have adequate folate levels.
Things to consider

Folate supplementation can mask Vitamin B12 deficiency and may interact with ADHD stimulant medications like methylphenidate.

Study evidence

12 studies

Folate may improve selected cognitive abilities in certain older adults or people with low folate, but it is not established as a general focus enhancer. Direct attention-related research is mixed, and nutritional status, vitamin B12 status and the population studied matter.

View goal
Showing 6 of 12 goals

Studies

Research connections will load here.
Sources

Up to five highest-ranked published examples per goal. Study counts and charts include all published studies for the connection.

  1. One-carbon metabolism-related compounds are associated with epigenetic aging biomarkers: results from the cross-sectional National Health and Nutrition Examination Survey 1999-2002.
    Bozack AK; Khodasevich D; Nwanaji-Enwerem JC; Gladish N; Shen H; Daredia S; Gamble M; Needham BL; Rehkopf DH; Cardenas A · The American journal of clinical nutrition · 2025
    Cross-sectional study2,346 participantsAnti-Aging
  2. Longitudinal associations of one-carbon metabolism biomarkers with biological and epigenetic aging in older adults in India.
    Wang J; Crimmins E; Kim JK; Chang NS; Dey S; Lee J; Thyagarajan B; Vivek S · GeroScience · 2026
    Cohort studyAnti-Aging
  3. Associations between leukocyte telomere length and three measures of folate status: a cross-sectional analysis of NHANES 1999-2002.
    Xue Q; Chen H · Frontiers in nutrition · 2026
    Cross-sectional study7,324 participantsAnti-Aging
  4. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging.
    Kado DM; Karlamangla AS; Huang MH; Troen A; Rowe JW; Selhub J; Seeman TE · The American journal of medicine · 2005
    Cohort study499 participantsAnti-Aging
  5. Blood folate is associated with asymptomatic or partially symptomatic Alzheimer's disease in the Nun study.
    Wang H; Odegaard A; Thyagarajan B; Hayes J; Cruz KS; Derosiers MF; Tyas SL; Gross MD · Journal of Alzheimer's disease : JAD · 2012
    Cohort study60 participantsAnti-Aging
  6. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis.
    Wang Z; Zhu W; Xing Y; Jia J; Tang Y · Nutrition reviews · 2022
    Meta-analysis46,175 participants95 studies pooledBrain HealthCognitive Support
  7. Folate and long-chain polyunsaturated fatty acid supplementation during pregnancy has long-term effects on the attention system of 8.5-y-old offspring: a randomized controlled trial.
    Catena A; Muñoz-Machicao JA; Torres-Espínola FJ; Martínez-Zaldívar C; Diaz-Piedra C; Gil A; Haile G; Györei E; Molloy AM; Decsi T; Koletzko B; Campoy C · The American journal of clinical nutrition · 2016
    Randomized trial136 participantsBrain HealthMental Focus
  8. Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial.
    Liu Y; Yu Z; Cai Z; Zhao L; Wang Y; Guo Y; Su X; Miao Y; Yi B; Wang Y; Zhang X · The journal of prevention of Alzheimer's disease · 2025
    Randomized trial220 participantsBrain Health
  9. Circulating folate concentrations and the risk of mild cognitive impairment: A prospective study on the older Chinese population without folic acid fortification.
    Fu J; Liu Q; Zhu Y; Sun C; Duan H; Huang L; Zhou D; Wang Z; Zhao J; Li Z; Ma F; Li W; Liu H; Zhang X; Chen Y; Wang G; Du Y; Huang G · European journal of neurology · 2022
    Cohort study3,974 participantsBrain Health
  10. Normal-But-Low Serum Folate Levels and the Risks for Cognitive Impairment.
    Jang S; Han JW; Shin J; Kim TH; Kwak KP; Kim K; Kim BJ; Kim SG; Kim JL; Kim TH; Moon SW; Park JY; Park JH; Byun S; Suh SW; Seo J; So Y; Ryu SH; Youn JC; Lee KH; Lee DY; Lee DW; Lee SB; Lee JJ; Lee JR; Jeong H; Jeong HG; Jhoo JH; Han K; Hong JW; Kim KW · Psychiatry investigation · 2020
    Cohort study3,910 participantsBrain Health
  11. Effects of 6-Month Folic Acid Supplementation on Cognitive Function and Blood Biomarkers in Mild Cognitive Impairment: A Randomized Controlled Trial in China.
    Ma F; Wu T; Zhao J; Han F; Marseglia A; Liu H; Huang G · The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Randomized trial180 participantsCognitive Support
  12. Serum folate and B12 levels in association with cognitive impairment among seniors: results from the VELESTINO study in Greece and meta-analysis.
    Michelakos T; Kousoulis AA; Katsiardanis K; Dessypris N; Anastasiou A; Katsiardani KP; Kanavidis P; Stefanadis C; Papadopoulos FC; Petridou ET · Journal of aging and health · 2013
    Meta-analysis8,122 participants9 studies pooledCognitive Support
  13. Homocysteine and folate as risk factors for dementia and Alzheimer disease.
    Ravaglia G; Forti P; Maioli F; Martelli M; Servadei L; Brunetti N; Porcellini E; Licastro F · The American journal of clinical nutrition · 2005
    Cohort study816 participantsCognitive Support
  14. Folate mediates cognitive impairment of aged people with periodontitis.
    Liu F; Liu Y; Feng Y; Zhao J; Wang M; Ye M; Zhang Y; Gan X; Pan Q; Shen J · Nutritional neuroscience · 2025
    Cross-sectional study1,966 participantsCognitive Support
  15. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
    Asgarshirazi M; Shariat M; Sheikh M · Hepatobiliary & pancreatic diseases international : HBPD INT · 2018
    Randomized trial55 participantsDetoxification
  16. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.
    Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC · The American journal of clinical nutrition · 2022
    Meta-analysis30,368 participants22 studies pooledDetoxification
  17. Serum folate levels and urinary arsenic methylation profiles in the US population: NHANES, 2003-2012.
    Zhang X; Xu X; Zhong Y; Power MC; Taylor BD; Carrillo G · Journal of exposure science & environmental epidemiology · 2020
    Cross-sectional study11,016 participantsDetoxification
  18. Association between serum folate levels and blood concentrations of cadmium and lead in US adults.
    Wu Z; Hu H; Wang C; Wu J; Xiong Y; Fu Y; Cheng X; Su H; Li P · Environmental science and pollution research international · 2022
    Cross-sectional study15,501 participantsDetoxification
  19. Effects of Folic Acid Supplementation on Liver Enzymes, Lipid Profile, and Insulin Resistance in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
    Molaqanbari MR; Zarringol S; Talari HR; Taghizadeh M; Bahmani F; Mohtashamian A; Ebrahimzadeh A; Sharifi N · Advanced biomedical research · 2023
    Randomized trial66 participantsDetoxification
  20. Intakes of Folate, Vitamin B6, and Vitamin B12 in Relation to All-Cause and Cause-Specific Mortality: A National Population-Based Cohort.
    Bo Y; Xu H; Zhang H; Zhang J; Wan Z; Zhao X; Yu Z · Nutrients · 2022
    Cohort study55,569 participantsGeneral Health
  21. The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study.
    Schorah CJ; Devitt H; Lucock M; Dowell AC · European journal of clinical nutrition · 1998
    Randomized trial119 participantsGeneral Health
  22. Associations of Serum Folate and Homocysteine Concentrations with All-Cause, Cardiovascular Disease, and Cancer Mortality in Men and Women in Korea: the Cardiovascular Disease Association Study.
    Song S; Song BM; Park HY · The Journal of nutrition · 2023
    Cohort study21,260 participantsGeneral Health
  23. The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA.
    Seyoum Tola F · Medicine · 2024
    Systematic reviewGeneral Health
  24. Systematic review of adverse health outcomes associated with high serum or red blood cell folate concentrations.
    Colapinto CK; O'Connor DL; Sampson M; Williams B; Tremblay MS · Journal of public health (Oxford, England) · 2017
    Systematic review71,847 participants46 studies pooledGeneral Health
  25. Cerebral folate receptor autoantibodies in autism spectrum disorder.
    Frye RE; Sequeira JM; Quadros EV; James SJ; Rossignol DA · Molecular psychiatry · 2014
    Non-randomized trial93 participantsMental Focus
  26. Folate, vitamin B-12, and cognitive function in the Boston Puerto Rican Health Study.
    Boumenna T; Scott TM; Lee JS; Palacios N; Tucker KL · The American journal of clinical nutrition · 2026
    Cross-sectional study1,408 participantsMental Focus
  27. Vitamins B9 and B12 in children with attention deficit hyperactivity disorder (ADHD).
    Razavinia F; Ebrahimiyan A; Faal Siahkal S; Ghazinezhad N; Abedi P · International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition · 2024
    Meta-analysis982 participants6 studies pooledMental Focus
  28. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Surman C; Ceranoglu A; Vaudreuil C; Albright B; Uchida M; Yule A; Spencer A; Boland H; Grossman R; Rhodewalt L; Fitzgerald M; Biederman J · Journal of clinical psychopharmacology · 2019
    Randomized trial44 participantsMental Focus
  29. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials.
    Firth J; Teasdale SB; Allott K; Siskind D; Marx W; Cotter J; Veronese N; Schuch F; Smith L; Solmi M; Carvalho AF; Vancampfort D; Berk M; Stubbs B; Sarris J · World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Systematic review10,951 participants33 studies pooledMood Support
  30. Continuous supplementation of folic acid in pregnancy and the risk of perinatal depression-A meta-analysis.
    Jin X; Cheng Z; Yu X; Tao Q; Huang R; Wang S · Journal of affective disorders · 2022
    Meta-analysis26,275 participants15 studies pooledMood Support
  31. Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials.
    Borges-Vieira JG; Cardoso CKS · Nutritional neuroscience · 2023
    Systematic review2,256 participants20 studies pooledMood Support
  32. Folate supplementation as a beneficial add-on treatment in relieving depressive symptoms: A meta-analysis of meta-analyses.
    Gao S; Khalid A; Amini-Salehi E; Radkhah N; Jamilian P; Badpeyma M; Zarezadeh M · Food science & nutrition · 2024
    Meta-analysis11 studies pooledMood Support
  33. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study.
    Passeri M; Cucinotta D; Abate G; Senin U; Ventura A; Stramba Badiale M; Diana R; La Greca P; Le Grazie C · Aging (Milan, Italy) · 1993
    Randomized trial96 participantsMood Support
  34. Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort.
    Zhang B; Dong H; Xu Y; Xu D; Sun H; Han L · European journal of clinical nutrition · 2023
    Cohort study115,664 participantsCardiovascular Support
  35. Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
    Shi M; Zheng J; Liu Y; Mao X; Wu X; Chu M; Niu H; Sun L; Chang X; He Y; Liu Y; Guo D; Zhang Y; Zhu Z; Zhao J · Journal of the American Heart Association · 2024
    Cohort study3,530 participantsCardiovascular Support
  36. Effect of folic acid on endothelial function following acute myocardial infarction.
    Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ · The American journal of cardiology · 2007
    Randomized trial40 participantsCardiovascular Support
  37. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
    Mangoni AA; Sherwood RA; Swift CG; Jackson SH · Journal of internal medicine · 2003
    Randomized trial24 participantsCardiovascular Support
  38. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
    Verhaar MC; Wever RM; Kastelein JJ; van Dam T; Koomans HA; Rabelink TJ · Circulation · 1998
    Non-randomized trial20 participantsCardiovascular Support
  39. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients.
    Qin X; Li J; Spence JD; Zhang Y; Li Y; Wang X; Wang B; Sun N; Chen F; Guo J; Yin D; Sun L; Tang G; He M; Fu J; Cai Y; Shi X; Ye P; Chen H; Zhao S; Chen M; Gao C; Kong X; Hou FF; Huang Y; Huo Y · Stroke · 2017
    Randomized trial20,702 participantsHeart Health
  40. Periconception Red Blood Cell Folate and Offspring Congenital Heart Disease : Nested Case-Control and Mendelian Randomization Studies.
    Chen H; Zhang Y; Wang D; Chen X; Li M; Huang X; Jiang Y; Dou Y; Wang Y; Ma X; Sheng W; Jia B; Yan W; Huang G; SPCC (Shanghai Preconception Cohort) Group · Annals of internal medicine · 2022
    Case-control study985 participantsHeart Health
  41. Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies.
    Jayedi A; Zargar MS · Critical reviews in food science and nutrition · 2020
    Meta-analysis369,746 participants11 studies pooledHeart Health
  42. Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.
    Fallah M; Karim Dehnavi M; Lotfi K; Aminianfar A; Azadbakht L; Esmaillzadeh A · Nutrition reviews · 2025
    Meta-analysis423,304 participants25 studies pooledHeart Health
  43. The association between folic acid supplementation and congenital heart defects: Systematic review and meta-analysis.
    Wondemagegn AT; Afework M · SAGE open medicine · 2022
    Meta-analysis37 studies pooledHeart Health
  44. Influence of folic acid on postprandial endothelial dysfunction.
    Wilmink HW; Stroes ES; Erkelens WD; Gerritsen WB; Wever R; Banga JD; Rabelink TJ · Arteriosclerosis, thrombosis, and vascular biology · 2000
    Randomized trial20 participantsStress Relief
  45. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Bahmani F; Karamali M; Shakeri H; Asemi Z · Clinical endocrinology · 2015
    Randomized trial69 participantsStress Relief
  46. Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials.
    Taylor MJ; Carney SM; Goodwin GM; Geddes JR · Journal of psychopharmacology (Oxford, England) · 2004
    Meta-analysis247 participants3 studies pooledStress Relief
  47. Depressive symptoms and associated factors among women preparing for pregnancy: a population-based study from the Seoul metropolitan preconception health management program.
    Lee HJ; Shin W; Han JY; Choi HZ; Kang J; Woo SY · BMC women's health · 2026
    Cross-sectional study14,004 participantsStress Relief
  48. Folate administration decreases oxidative status and blood pressure in postmenopausal women.
    Cagnacci A; Cannoletta M; Xholli A; Piacenti I; Palma F; Palmieri B · European journal of nutrition · 2016
    Randomized trial30 participantsStress Relief
  49. Association between RBC folate and lumbar bone mineral density in postmenopausal women, a cross-sectional study from NHANES 2009-2018.
    Wei H; Jin Z; Zhou L; Tang G; Chai S; Che X; Tan Y; Zeng W · Frontiers in endocrinology · 2025
    Cross-sectional study1,315 participantsBone Health
  50. Genetic variants modify the associations of concentrations of methylmalonic acid, vitamin B-12, vitamin B-6, and folate with bone mineral density.
    Liu CT; Karasik D; Xu H; Zhou Y; Broe K; Cupples LA; Cpgm de Groot L; Ham A; Hannan MT; Hsu YH; Jacques P; McLean RR; Paul L; Selhub J; Trajanoska K; van der Velde N; van Schoor N; Kiel DP · The American journal of clinical nutrition · 2021
    Cohort study4,310 participantsBone Health
  51. Adequate Intake and Supplementation of B Vitamins, in Particular Folic Acid, can Play a Protective Role in Bone Health.
    Rondanelli M; Tartara A; Fossari F; Vecchio V; Faliva MA; Naso M; Perna S; Nichetti M; Peroni G · Current aging science · 2022
    Narrative review35,298 participants29 studies pooledBone Health
  52. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women.
    Cagnacci A; Baldassari F; Rivolta G; Arangino S; Volpe A · Bone · 2004
    Cross-sectional study161 participantsBone Health
  53. Dietary intake of folate, but not vitamin B2 or B12, is associated with increased bone mineral density 5 years after the menopause: results from a 10-year follow-up study in early postmenopausal women.
    Rejnmark L; Vestergaard P; Hermann AP; Brot C; Eiken P; Mosekilde L · Calcified tissue international · 2008
    Cohort study1,869 participantsBone Health
  54. Hair Loss After Metabolic and Bariatric Surgery: a Systematic Review and Meta-analysis.
    Zhang W; Fan M; Wang C; Mahawar K; Parmar C; Chen W; Yang W; Global Bariatric Research Collaborative · Obesity surgery · 2021
    Meta-analysis2,538 participants18 studies pooledHair Health
  55. Quantitative Analysis of Selected Circulating Hematological Biomarkers, Essential Minerals, Vitamins, and Thyroid Hormones in Females Affected by Hair Loss.
    Al-Fawaeir S; Al-Odat I · Diseases (Basel, Switzerland) · 2025
    Case-control study200 participantsHair Health
  56. Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.
    Saini A; Norman AR; Cunningham D; Chau I; Hill M; Tait D; Hickish T; Iveson T; Lofts F; Jodrell D; Ross PJ; Oates J · British journal of cancer · 2003
    Randomized trialHair Health
  57. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
    Jonker D; Rumble RB; Maroun J; Gastrointestinal Cancer Disease Site Groupof Cancer Care Ontario’s Program in Evidence-Based Care · Current oncology (Toronto, Ont.) · 2012
    Randomized trialHair Health
  58. Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
    Nolè F; de Braud F; Aapro M; Minchella I; De Pas TM; Zampino MG; Monti S; Andreoni G; Goldhirsch A · Annals of oncology : official journal of the European Society for Medical Oncology · 1997
    Randomized trialHair Health